Know Cancer

or
forgot password

    • cancer clinical trials in las vegas, NV

    • Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    University Medical Center of Southern Nevada
    Las Vegas, Nevada 89102
    Melanoma (Skin)
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Women's Cancer Center of Nevada
    Las Vegas, Nevada 89109
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    CCOP - Nevada Cancer Research Foundation

    Trial Locations
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
    Women's Cancer Center of Nevada
    Las Vegas, Nevada 89109
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    CCOP - Nevada Cancer Research Foundation
    Las Vegas, Nevada 89109-2306
    Lymphoma, Lymphoproliferative Disorder
    Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
    CCOP - Nevada Cancer Research Foundation

    Trial Locations
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Leukemia
    Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
    Nevada Cancer Institute Dept. of Nevada Cancer (3)

    Trial Locations
    Nevada Cancer Institute Dept. of Nevada Cancer (3)
    Comprehensive Cancer Centers of Nevada CCC of Nevada Henderson (4)
    HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
    Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Women's Cancer Center of Nevada
    Las Vegas, Nevada 89109
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Women's Cancer Center of Nevada
    Las Vegas, Nevada 89109
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
    CCOP - Nevada Cancer Research Foundation
    Las Vegas, Nevada 89109-2306
    Leukemia
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    University Medical Center of Southern Nevada

    Trial Locations
    University Medical Center of Southern Nevada
    Nevada Cancer Research Foundation CCOP
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
    Nevada Cancer Institute NVCC - Huntsman
    Las Vegas, Nevada 89135
    Melanoma
    A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Non Small Cell Lung Cancer
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Nevada Cancer Research Foundation CCOP
    Las Vegas, Nevada 89106
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
    Nevada Cancer Institute
    Las Vegas, Nevada 89135
    Prostate Cancer
    Survey of Inhibitors in Plasma-Product Exposed Toddlers
    Hemophilia Treatment Center of Las Vegas
    Las Vegas, Nevada 89109
    Hemophilia A
    PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
    Comprehensive Cancer Centers of Nevada
    Las Vegas, Nevada 89109
    Breast Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    Women's Cancer Center - La Canada
    Las Vegas, Nevada 89169
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    Southern Nevada Cancer Research Foundation
    Las Vegas, Nevada 89106
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    Southern Nevada Cancer Research Foundation
    Las Vegas, Nevada 89106
    Multiple Myeloma
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Women's Cancer Center of Nevada
    Las Vegas, Nevada 89109
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
    CCOP - Nevada Cancer Research Foundation

    Trial Locations
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Malignant Mesothelioma
    Study in Head and Neck Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Las Vegas, Nevada 89169
    Head and Neck Neoplasms
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    CCOP - Nevada Cancer Research Foundation

    Trial Locations
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Sunrise Hospital and Medical Center

    Trial Locations
    Sunrise Hospital and Medical Center
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Kidney Cancer
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    CCOP - Nevada Cancer Research Foundation
    Las Vegas, Nevada 89109-2306
    Breast Cancer
    Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
    University Medical Center of Southern Nevada
    Las Vegas, Nevada 89102
    Lymphoma
    Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Women's Cancer Center of Nevada
    Las Vegas, Nevada 89109
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Nevada Cancer Research Foundation CCOP

    Trial Locations
    Nevada Cancer Research Foundation CCOP
    Nevada Cancer Institute-Summerlin Campus
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    CCOP - Nevada Cancer Research Foundation

    Trial Locations
    CCOP - Nevada Cancer Research Foundation
    University Medical Center of Southern Nevada
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Women's Cancer Center of Nevada
    Las Vegas, Nevada 89109
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
    Women's Cancer Center of Nevada
    Las Vegas, Nevada 89109
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Participants Who Received Prior First Line Platinum Based Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Las Vegas, Nevada 89169
    Non Small Cell Lung Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Nevada Cancer Research Foundation CCOP
    Las Vegas, Nevada 89106
    Light Chain Deposition Disease, Smoldering Multiple Myeloma